Covered recipient · General Payments record
AMIT KEITH CORREA
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2025
$10,546.43
- Reported across 181 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,000.00 | 1 |
| Food and Beverage | $1,475.22 | 60 |
| Travel and Lodging | $1,439.24 | 3 |
| Education | $159.47 | 3 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AVYXA PHARMA, LLC | $3,734.76 | 7 |
| Celgene Corporation | $195.19 | 10 |
| E.R. Squibb & Sons, L.L.C. | $147.29 | 8 |
| PFIZER INC. | $132.44 | 6 |
| Acerta Pharma LLC | $86.40 | 2 |
| SEAGEN INC. | $74.99 | 1 |
| Syndax Pharmaceuticals, Inc. | $72.81 | 3 |
| Merck Sharp & Dohme Corporation | $69.91 | 4 |
| Gilead Sciences, Inc. | $60.88 | 2 |
| GlaxoSmithKline, LLC. | $52.87 | 3 |
| PharmaEssentia USA Corporation | $48.68 | 2 |
| GENZYME CORPORATION | $44.11 | 2 |
| Daiichi Sankyo Inc. | $43.31 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $39.79 | 1 |
| Tempus AI, Inc | $29.48 | 1 |
| Janssen Biotech, Inc. | $28.32 | 2 |
| Adaptive Biotechnologies Corporation | $24.97 | 1 |
| TerSera Therapeutics LLC | $23.47 | 1 |
| Deciphera Pharmaceuticals Inc. | $22.88 | 1 |
| BeOne Medicines USA, Inc. | $20.59 | 1 |
| Lilly USA, LLC | $18.71 | 1 |
| Spectrum Pharmaceuticals Inc. | $18.44 | 1 |
| Genmab U.S., Inc. | $18.01 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $17.12 | 1 |
| Nuvation Bio Inc. | $16.65 | 1 |
| Legend Biotech USA Inc. | $15.99 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (67)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.